1. Home
  2. IGR vs EMBC Comparison

IGR vs EMBC Comparison

Compare IGR & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGR
  • EMBC
  • Stock Information
  • Founded
  • IGR 2004
  • EMBC 1924
  • Country
  • IGR United States
  • EMBC United States
  • Employees
  • IGR N/A
  • EMBC N/A
  • Industry
  • IGR Finance Companies
  • EMBC Medical/Dental Instruments
  • Sector
  • IGR Finance
  • EMBC Health Care
  • Exchange
  • IGR Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • IGR 776.6M
  • EMBC 782.5M
  • IPO Year
  • IGR N/A
  • EMBC N/A
  • Fundamental
  • Price
  • IGR $4.85
  • EMBC $13.78
  • Analyst Decision
  • IGR
  • EMBC Buy
  • Analyst Count
  • IGR 0
  • EMBC 2
  • Target Price
  • IGR N/A
  • EMBC $18.50
  • AVG Volume (30 Days)
  • IGR 747.7K
  • EMBC 313.8K
  • Earning Date
  • IGR 01-01-0001
  • EMBC 11-25-2025
  • Dividend Yield
  • IGR 13.93%
  • EMBC 4.33%
  • EPS Growth
  • IGR N/A
  • EMBC 18.26
  • EPS
  • IGR N/A
  • EMBC 1.42
  • Revenue
  • IGR N/A
  • EMBC $1,102,500,000.00
  • Revenue This Year
  • IGR N/A
  • EMBC N/A
  • Revenue Next Year
  • IGR N/A
  • EMBC N/A
  • P/E Ratio
  • IGR N/A
  • EMBC $9.75
  • Revenue Growth
  • IGR N/A
  • EMBC N/A
  • 52 Week Low
  • IGR $3.88
  • EMBC $9.20
  • 52 Week High
  • IGR $5.70
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • IGR 43.79
  • EMBC 48.53
  • Support Level
  • IGR $4.78
  • EMBC $13.34
  • Resistance Level
  • IGR $4.93
  • EMBC $13.92
  • Average True Range (ATR)
  • IGR 0.08
  • EMBC 0.47
  • MACD
  • IGR -0.01
  • EMBC -0.02
  • Stochastic Oscillator
  • IGR 43.85
  • EMBC 49.34

About IGR CBRE Global Real Estate Income Fund of Beneficial Interest

CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: